Indication-Based Pricing Sparks Interest In UK
Experts Advocate Flexible Drug Pricing Models For NHS
Different prices for different medical conditions treated by the same drug and tying drug prices to the benefits they deliver are some of the recommendations made by a cross-sector expert panel to improve patient access to innovative cancer medicines.
